Search

You searched for "Cornea"

981 results found

Minimally Invasive Glaucoma Surgery: What options are there and when might they be considered?

25 March 2024 | | EYE - Glaucoma
In recent years there has been a rapid expansion in a group of operations termed ‘minimally invasive’ or ‘micro invasive’ glaucoma surgery (MIGS). These options generally offer less significant IOP reduction, but with a more favourable safety profile when compared...

Ophthalmic exposure for emergency medicine doctors

2 August 2024 | | EYE - General
Emergency medicine is a challenging specialty which requires managing a range of acute issues. In this article, I explore the experiences of emergency doctors towards ophthalmic cases presenting in the emergency department, identifying what initiatives have helped trainees. Emergency medicine...

Glaucoma: 30 years on

30 November 2023
Back in 1993, the late and great Barry Cullen FRCS (Cavan born, Dublin trained), the first editor of Eye News, asked me to write an article about the current treatment of chronic open angle glaucoma (COAG). At the time I...

AI & Oculomics: a new section for Eye News

2 February 2024 | | EYE - General
Inaugurating this new regular section on the exciting landscape of AI and oculomics, we provide an overview which delves into the historical context and the etymology of this field, reviews the current state of play and contemplates possibilities and hopes...

Pigmented paravenous retinochoroidal atrophy

4 December 2024 | | EYE - Imaging, EYE - Vitreo-Retinal
Presentation A 46-year-old Caucasian female was referred to the eye clinic by her local optician following a routine sight test. She was noted to have pigmentary retinal changes in both eyes but was asymptomatic with no visual complaints. At presentation...

Happy hour

3 August 2023 |
Welcome Eye News Aug/Sep 2023, your bi-monthly tonic for a much-needed happy hour. In the current climate of challenge across all fronts, there’s no better time to reach out for the professional equivalent of a cheery cup in the company...

Unconscious bias (part 2)

5 February 2020 | | EYE - General
Does unconscious bias exist, and does training help to reduce discriminatory behaviour? Clare Inkster questions her role as a trainer. I read Gwyn Williams’ Learning Curve article on this topic a few months ago with interest, and as someone who...

What's trending Oct/Nov 2021

1 October 2021 | | EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #cataracts #holography #simulation Cataracts are the major cause of blindness globally and innovating novel management strategies remains as important as ever...

OSA members call for a 5-year practice plan at 100% Optical

12 January 2024 | industry, BIB, 100% Optical, 100% ophthalmology
Making a five-year plan for an optical or ophthalmology business is uppermost in OSA members’ minds as they look for the best means of supporting the profession at 100% Optical.

Did you need a mulligan, laddie?!

4 August 2025 |
Scotland is the home of golf. Golfing parlance infiltrates all walks of life here, including eye hospitals. It seems that my personal opinion on my compatriot Rory McIlroy’s completion of the golfing career grand slam is much more important to...

Jun/Jul 2015 Quiz

1 June 2015 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
History A 35-year-old male presents with bilateral corneal opacities. Examination shows a honeycomb-type dystrophy. A penetrating keratoplasty is performed and the specimen sent for ophthalmic histopathological assessment. Figure 1 is the haemotoxylin & eosin (H&E). Figure 2 is a Masson...

21st Century retinal laser treatment in the anti-VEGF era

1 June 2017 | | EYE - Vitreo-Retinal
In today’s world, macular laser treatment has a vital role in the treatment of diabetic macular oedema (DMO). DMO is one of the most common causes of visual impairment. Despite expensive intravitreal treatment courses of anti-VEGF, many will agree that...